8-K
filed November 9, 2023, 6:59 PM ET
ticker CYDY
CIK 0001175680
other material
confidence high
sentiment negative
materiality 0.65
CytoDyn shareholders approve authorized common stock increase to 1.75B shares
CytoDyn Inc.
- Authorized shares increased from 1.35B to 1.75B, approved by 504.7M for vs 42.6M against.
- All five director nominees elected: Tanya Durkee Urbach, Stephen Simes, Ryan Dunlap, Lishomwa Ndhlovu, Karen Brunke.
- Advisory vote on named executive officer compensation passed with 297.5M for, 63.6M against, 14.2M abstentions.
- Share increase effective immediately upon filing Certificate of Amendment with Delaware Secretary of State on Nov 9, 2023.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
CytoDyn Inc.: Increased authorized shares of common stock from 1,350,000,000 to 1,750,000,000 (effective 2023-11-09).
- Change
- charter amendment
- Effective
- 2023-11-09
Exact text from the filing
On November 9, 2023, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Certificate of Amendment”) to its Certificate of Incorporation, increasing the total number of authorized shares of common stock, par value $0.001 per share, from 1,350,000,000 to 1,750,000,000.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CytoDyn Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2023-11-09 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-11-09
Exact text from the filing
The stockholders approved, on an advisory basis, the compensation paid to the Company’s named executive officers.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CytoDyn Inc. shareholders approved Vote to amend the Company’s certificate of incorporation to increase the total number of authorized shares of common stock from 1,350,000,000 to 1,750,000,000 shares at the 2023-11-09 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2023-11-09
Exact text from the filing
The stockholders approved an amendment to the Company’s certificate of incorporation to increase the total number of authorized shares of common stock from 1,350,000,000 to 1,750,000,000 shares.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CytoDyn Inc. shareholders approved Election of Directors at the 2023-11-09 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-11-09
Exact text from the filing
The stockholders elected each of the Company’s director nominees to serve until the Company’s 2024 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.